Universal Biosensors Inc
ASX:UBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
S&P Global Inc
F:MHL
|
US |
|
Pacific Textiles Holdings Ltd
HKEX:1382
|
HK |
|
Rouchon Industries Inc
OTC:RCHN
|
US |
Universal Biosensors Inc
Other Items
Universal Biosensors Inc
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
U
|
Universal Biosensors Inc
ASX:UBI
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Somnomed Ltd
ASX:SOM
|
Other Items
AU$2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
Cochlear Ltd
ASX:COH
|
Other Items
-AU$19.1m
|
CAGR 3-Years
33%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Other Items
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Other Items
-AU$8.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Universal Biosensors Inc
Glance View
Universal Biosensors, Inc. engages in the research, development and manufacture of medical diagnostics test systems for point-of-care professional and home use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-12-13. The firm is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, COVID-19, women’s health and fertility, non-human and environmental testing using its patented platform technology and hand-held point of use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system using opposing electrodes that detects specific analytes in samples as small as a droplet. Its products include Sentia, a wine analyzer, and Xprecia Prime, a coagulation analyzer. Its Hemostasis Reference Laboratory Meso Scale Discovery (MSD) multiplex platform couples immunoassay methodology with electrochemiluminescence (ECL) detection to provide measurement of a multitude of different cytokine panels. Its laboratory services include assay validation and analysis and consultation for study design.
